Press release
Chronic Inflammation Treatment Market Size, Trends & Growth Forecast 2024-2031 | Pfizer Inc., NodThera, Abcentra.
Chronic Inflammation Treatment Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/chronic-inflammation-treatment-market?sz
What is the projected growth of the Global Chronic Inflammation Treatment market?
The Global Chronic Inflammation Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
What is Chronic Inflammation Treatment Market?
The Chronic Inflammation Treatment Market focuses on therapies addressing long-term inflammatory conditions like arthritis, asthma, and inflammatory bowel disease. Driven by rising cases of autoimmune disorders and lifestyle-related diseases, the market includes biologics, NSAIDs, corticosteroids, and emerging regenerative therapies. Advances in precision medicine and growing demand for targeted treatments are shaping its growth.
Transform your pharma strategy with expert insights and competitive analysis: https://www.datamintelligence.com/competitive-intelligence/contact
Who are the major players in the Chronic Inflammation Treatment market?
The prominent players in Chronic Inflammation Treatment market research report are:
Pfizer Inc., NodThera, Abcentra, Evommune, Inc., Sterna biologicals, Halia Therapeutics, Inc., Amgen Inc., AstraZeneca, Takeda Pharmaceutical Company Limited and Annexon, Inc. among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
On August 7, 2023, Halia Therapeutics announced the completion of participant enrollment for its Phase I study (NCT05447546) evaluating HT-6184, the company's lead candidate for treating chronic inflammation. HT-6184 works by inhibiting NLRP3 inflammasome activity, specifically targeting the NEK7 protein through an allosteric mechanism. This milestone marks a significant step forward in Halia's mission to develop innovative treatments for inflammation-related diseases.
On April 26, 2023, clinical-stage biotechnology company Evommune, Inc. secured $50 million in a Series B funding round to advance its research into novel therapies for inflammatory diseases. The round was co-led by new investor Arix Bioscience alongside EQT Life Sciences, SymBiosis, and several existing investors. Additional participants included Amplitude Ventures, another new investor, as well as Series A backers Andera Partners and Pivotal bioVenture Partners. This funding will support Evommune's continued efforts in developing breakthrough treatments for chronic inflammation.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/chronic-inflammation-treatment-market
Market Segments
By Type: Nonspecific Proliferative, Granulomatous Inflammation (Foreign Body Granuloma, Infectious Granuloma).
By Medications: Metformin, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (Naproxen, Ibuprofen, Aspirin), Statins (Simvastatin, Rosuvastatin), Corticosteroids (Cortisone, Prednisone), Herbal Supplements.
By Chronic Inflammation Disease Type: Diabetes, Cardiovascular Diseases, Arthritis and Joint Diseases, Chronic Obstructive Pulmonary Disease (COPD), Allergies, Others.
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.
The Chronic Inflammation Treatment industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Chronic Inflammation Treatment Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/chronic-inflammation-treatment-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Inflammation Treatment Market Size, Trends & Growth Forecast 2024-2031 | Pfizer Inc., NodThera, Abcentra. here
News-ID: 3889728 • Views: …
More Releases from DataM Intelligence 4Market Research
Idiopathic Pulmonary Fibrosis Market is expected to reach US$ 8.25 Billion by 20 …
Market Size and Growth:
The Global Idiopathic Pulmonary Fibrosis Market size reached US$ 4.24 Billion in 2024 from US$ 3.96 Billion in 2023 and is expected to reach US$ 8.25 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
Idiopathic Pulmonary Fibrosis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence,…
Global Wound Debridement Products Market Set to Surge with Innovative Solutions …
Market Overview:
The Wound Debridement Products Market is estimated to grow at a CAGR of 5.9% during the forecast period 2024-2031
Wound Debridement Products Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods,…
Global Vocal Fold Augmentation Market Set to Soar: Innovative Solutions Transfor …
Market Size and Growth:
The Global Vocal Fold Augmentation Market reached US$ 2,042.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,642.8 million by 2031. The vocal fold augmentation market is expected to exhibit a CAGR of 3.3% during the forecast period 2024-2031.
Vocal Fold Augmentation Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging…
Central Venous Catheters Market is estimated to reach US$ 3,760.83 Million by 20 …
Market Size and Growth:
The Central Venous Catheters Market size was valued US$ 1,994.72 million in 2021 and is estimated to reach US$ 3,760.83 million by 2031, growing at a CAGR of 5.9% during the forecast period (2024-2031).
Central Venous Catheters Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
More Releases for Chronic
Chronic Pain Treatment Market - Relieving Chronic Pain: Discover the Latest Inno …
Newark, New Castle, USA: The "Chronic Pain Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Chronic Pain Treatment Market: https://www.growthplusreports.com/report/chronic-pain-treatment-market/8030
This latest report researches the industry structure,…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Chronic Hepatitis Therapeutics Market - Empowering Liver Health, Defying Chronic …
Newark, New Castle, USA - new report, titled Chronic Hepatitis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Hepatitis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Hepatitis Therapeutics market. The report offers an overview of…
Chronic Phase Chronic Myeloid Leukemia Market to Witness Growth by 2032, Estimat …
DelveInsight's "Chronic Phase Chronic Myeloid Leukemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Chronic Phase Chronic Myeloid Leukemia , historical and forecasted epidemiology as well as the Chronic Phase Chronic Myeloid Leukemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Chronic Phase Chronic Myeloid Leukemia market report provides current treatment practices, emerging drugs, the market share…
Boot chronic pain
For immediate release
Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue.
We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them…
